Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3938)
All Articles published online
|
Mar 28, 2008 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ai KX, Lu LY, Huang XY, Chen W, Zhang HZ. Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer. World J Gastroenterol 2008; 14(12): 1931-1935 [PMID: 18350635 DOI: 10.3748/wjg.14.1931] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i12/1931.htm |
| Number | Citing Articles |
| 1 |
ZIQUAN LIU, CHUANXIANG XU, JIANWEI ZHANG, YUNYUN CHEN, XIAOHUA LIU, LEI WU, ZHIQING ZHANG, XIANGYAN MENG, HONGTAO LIU, ZIFENG JIANG, TIANHUI WANG. Functionally active rat S100A4 from a polymerase chain reaction-synthesized gene expressed in soluble form in Escherichia coli. Oncology Letters 2014; 7(4): 1179 doi: 10.3892/ol.2014.1870
|
| 2 |
L-Z Feng, X-Y Zheng, L-X Zhou, B Fu, Y-W Yu, S-C Lu, N-S Cao. Correlation between Expression of S100A4 and VEGF-C, and Lymph Node Metastasis and Prognosis in Gastric Carcinoma. Journal of International Medical Research 2011; 39(4): 1333 doi: 10.1177/147323001103900420
|
| 3 |
Shuang Qu, Jiahui Wu, Qianyi Bao, Bing Yao, Rui Duan, Xiang Chen, Lingyun Li, Hongyan Yuan, Yucui Jin, Changyan Ma. Osterix promotes the migration and angiogenesis of breast cancer by upregulation of S100A4 expression. Journal of Cellular and Molecular Medicine 2019; 23(2): 1116 doi: 10.1111/jcmm.14012
|
| 4 |
Nobukazu Tsukamoto, Shinichi Egawa, Masanori Akada, Keiko Abe, Yuriko Saiki, Naoyuki Kaneko, Satoru Yokoyama, Kentaro Shima, Akihiro Yamamura, Fuyuhiko Motoi, Hisashi Abe, Hiroki Hayashi, Kazuyuki Ishida, Takuya Moriya, Takahiro Tabata, Emiko Kondo, Naomi Kanai, Zhaodi Gu, Makoto Sunamura, Michiaki Unno, Akira Horii. The Expression of S100A4 in Human Pancreatic Cancer Is Associated With Invasion. Pancreas 2013; 42(6): 1027 doi: 10.1097/MPA.0b013e31828804e7
|
| 5 |
Ahmed Abdel-Razik, Youssif ElMahdy, Ehab El hanafy, Rania Elhelaly, Rasha Elzehery, Ahmed M. Tawfik, Waleed Eldars. Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Malignant and Benign Biliary Obstructions. The American Journal of the Medical Sciences 2016; 351(3): 259 doi: 10.1016/j.amjms.2015.12.013
|
| 6 |
K Kaira, Y Sunose, K Arakawa, T Ogawa, N Sunaga, K Shimizu, H Tominaga, N Oriuchi, H Itoh, S Nagamori, Y Kanai, A Segawa, M Furuya, M Mori, T Oyama, I Takeyoshi. Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer. British Journal of Cancer 2012; 107(4): 632 doi: 10.1038/bjc.2012.310
|
| 7 |
Yu Wu, Qi Zhou, Fangyue Guo, Mingming Chen, Xufeng Tao, Deshi Dong. S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.711180
|
| 8 |
Daiyong Deng, Habeebunnisa Begum, Tong Liu, Jiangyan Zhang, Qiang Zhang, Ting-yu Chu, Hong Li, Alexander Lemenze, Mainul Hoque, Patricia Soteropoulos, Pingping Hou. NFAT5 governs cellular plasticity-driven resistance to KRAS-targeted therapy in pancreatic cancer. Journal of Experimental Medicine 2024; 221(11) doi: 10.1084/jem.20240766
|
| 9 |
Qiang Ding, Guo-qiang Cai, Meng Hu, Youfeng Yang, Anni Zheng, Qinjiu Tang, Candece L. Gladson, Haurko Hayasaka, Hongju Wu, Zhiying You, Brian D. Southern, Lisa M. Grove, S. Ohidar Rahaman, Haotian Fang, Mitchell A. Olman. FAK-Related Nonkinase Is a Multifunctional Negative Regulator of Pulmonary Fibrosis. The American Journal of Pathology 2013; 182(5): 1572 doi: 10.1016/j.ajpath.2013.01.026
|
| 10 |
Hua Li, Xiangdong Tian, Yong Xu, Yi Pan, Yubei Huang, Dejun Zhou, Zhenguo Song. Prognostic value of pre‑treatment peripheral blood markers in pancreatic ductal adenocarcinoma and their association with S100A4 expression in tumor tissue. Oncology Letters 2019; doi: 10.3892/ol.2019.10809
|
| 11 |
Yuezhu Wang, Chao Song, Jun Zhao, Yuexin Zhang, Xilong Zhao, Chenchen Feng, Guorui Zhang, Jiang Zhu, Fan Wang, Fengcui Qian, Liwei Zhou, Jian Zhang, Xuefeng Bai, Bo Ai, Xinyu Liu, Qiuyu Wang, Chunquan Li. SEdb 2.0: a comprehensive super-enhancer database of human and mouse. Nucleic Acids Research 2023; 51(D1): D280 doi: 10.1093/nar/gkac968
|
| 12 |
Takahiro Tabata, Nobukazu Tsukamoto, Abbas Ali Imani Fooladi, Sumitaka Yamanaka, Toru Furukawa, Masaharu Ishida, Daisuke Sato, Zhaodi Gu, Hiroki Nagase, Shinichi Egawa, Makoto Sunamura, Akira Horii. RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells. Biochemical and Biophysical Research Communications 2009; 390(3): 475 doi: 10.1016/j.bbrc.2009.09.096
|
| 13 |
LIYONG HUANG, YE XU, GUOXIANG CAI, ZUQING GUAN, SANJUN CAI. Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells. Oncology Reports 2012; 27(4): 917 doi: 10.3892/or.2011.1598
|
| 14 |
Shanshan Huang, Jiawei Zheng, Yufang Huang, Li Song, Yin Yin, Danzhen Ou, Shangxiang He, Xiong Chen, Xuenong Ouyang. Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. Disease Markers 2016; 2016: 1 doi: 10.1155/2016/8137378
|
| 15 |
Chung-Yuan Lee, Min-Chieh Hsin, Pei-Ni Chen, Chiao-Wen Lin, Po-Hui Wang, Shun-Fa Yang, Yi-Hsuan Hsiao. Arctiin Inhibits Cervical Cancer Cell Migration and Invasion through Suppression of S100A4 Expression via PI3K/Akt Pathway. Pharmaceutics 2022; 14(2): 365 doi: 10.3390/pharmaceutics14020365
|
| 16 |
Pulin Che, Youfeng Yang, Xiaosi Han, Meng Hu, Jeffery C. Sellers, Angelina I. Londono-Joshi, Guo-Qiang Cai, Donald J. Buchsbaum, John D. Christein, Qinjiu Tang, Dongquan Chen, Qianjun Li, William E. Grizzle, Yin Ying Lu, Qiang Ding. S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase. Scientific Reports 2015; 5(1) doi: 10.1038/srep08453
|
| 17 |
Chen Chen, Chang Qiang Wu, Tian Wu Chen, Meng Yue Tang, Xiao Ming Zhang. Molecular Imaging with MRI: Potential Application in Pancreatic Cancer. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/624074
|
| 18 |
Robert S O'Neill, Alina Stoita. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?. World Journal of Gastroenterology 2021; 27(26): 4045-4087 doi: 10.3748/wjg.v27.i26.4045
|
| 19 |
Fangyuan Gao, Fenglong Jiao, Chaoshuang Xia, Yang Zhao, Wantao Ying, Yuping Xie, Xiaoya Guan, Ming Tao, Yangjun Zhang, Weijie Qin, Xiaohong Qian. A novel strategy for facile serum exosome isolation based on specific interactions between phospholipid bilayers and TiO2. Chemical Science 2019; 10(6): 1579 doi: 10.1039/C8SC04197K
|
| 20 |
Ahmet Yildirim, Mustafa Tekpinar, Tsjerk A. Wassenaar. Competing Roles of Ca2+ and Nonmuscle Myosin IIA on the Dynamics of the Metastasis-Associated Protein S100A4. The Journal of Physical Chemistry B 2021; 125(36): 10059 doi: 10.1021/acs.jpcb.1c02096
|
| 21 |
Udayakumar Navaneethan, Norma G. Gutierrez, Ramprasad Jegadeesan, Preethi G. K. Venkatesh, Earl Poptic, Xiuli Liu, Madhusudhan R. Sanaka, Sunguk Jang, John J. Vargo, Mansour A. Parsi. Vascular Endothelial Growth Factor Levels in Bile Distinguishes Pancreatic Cancer from Other Etiologies of Biliary Stricture: A Pilot Study. Digestive Diseases and Sciences 2013; 58(10): 2986 doi: 10.1007/s10620-013-2764-0
|
| 22 |
NAM HEE KIM, HYE YOUN SUNG, EUN NAM CHOI, DAHYUN LYU, HYUCK JAE CHOI, WOONG JU, JUNG-HYUCK AHN. Aberrant DNA methylation in the IFITM1 promoter enhances the metastatic phenotype in an intraperitoneal xenograft model of human ovarian cancer. Oncology Reports 2014; 31(5): 2139 doi: 10.3892/or.2014.3110
|
| 23 |
R A Smith, J Tang, C Tudur-Smith, J P Neoptolemos, P Ghaneh. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. British Journal of Cancer 2011; 104(9): 1440 doi: 10.1038/bjc.2011.110
|
| 24 |
Johanna W. Hellinger, Silke Hüchel, Lena Goetz, Gerd Bauerschmitz, Günter Emons, Carsten Gründker. Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01074
|
| 25 |
Didem Saka, Muazzez Gökalp, Betül Piyade, Nedim Can Cevik, Elif Arik Sever, Derya Unutmaz, Güralp O. Ceyhan, Ihsan Ekin Demir, Hande Asimgil. Mechanisms of T-Cell Exhaustion in Pancreatic Cancer. Cancers 2020; 12(8): 2274 doi: 10.3390/cancers12082274
|
| 26 |
H Yang, K Zhao, Q Yu, X Wang, Y Song, R Li. Evaluation of Plasma and Tissue S100A4 Protein and mRNA Levels as Potential Markers of Metastasis and Prognosis in Clear Cell Renal Cell Carcinoma. Journal of International Medical Research 2012; 40(2): 475 doi: 10.1177/147323001204000209
|
| 27 |
D Ansari, A Rosendahl, J Elebro, R Andersson. Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. British Journal of Surgery 2011; 98(8): 1041 doi: 10.1002/bjs.7574
|
| 28 |
Sang Hyub Lee, Haeryoung Kim, Jin-Hyeok Hwang, Eun Shin, Hye Seung Lee, Dae Wook Hwang, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han, Byung Hyo Cha. CD24 and S100A4 Expression in Resectable Pancreatic Cancers With Earlier Disease Recurrence and Poor Survival. Pancreas 2014; 43(3): 380 doi: 10.1097/MPA.0000000000000097
|
| 29 |
Fuxin Jia, Mengmeng Liu, Xiao Li, Fen Zhang, Shuqiang Yue, Jiangwei Liu. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1707-4
|
| 30 |
Julie Garcia, Maria José Sandi, Pierre Cordelier, Bernard Binétruy, Jacques Pouysségur, Juan Lucio Iovanna, Roselyne Tournaire. Tie1 deficiency induces endothelial–mesenchymal transition. EMBO reports 2012; 13(5): 431 doi: 10.1038/embor.2012.29
|
| 31 |
DEGANG WANG, JIANWEI ZHANG, ZIQUAN LIU, YUNYUN CHEN, CHUANXIANG XU, ZHIQING ZHANG, XIAOHUA LIU, LEI WU, XUESI ZHOU, XIANGYAN MENG, HUA LI, HONGTAO LIU, ZIFENG JIANG, TIANHUI WANG. Functional expression, characterization and application of the human S100A4 protein. Molecular Medicine Reports 2015; 11(1): 175 doi: 10.3892/mmr.2014.2745
|
| 32 |
Daniel Ansari, William Torén, Qimin Zhou, Dingyuan Hu, Roland Andersson. Proteomic and genomic profiling of pancreatic cancer. Cell Biology and Toxicology 2019; 35(4): 333 doi: 10.1007/s10565-019-09465-9
|
| 33 |
Eun Ah Jung, Hyun Deuk Cho, Ji-Hye Lee, Mee-Hye Oh. Clinicopathological Significance of S100A4 Expression in Non-small Cell Lung Carcinomas. The Korean Journal of Pathology 2010; 44(5): 477 doi: 10.4132/KoreanJPathol.2010.44.5.477
|
| 34 |
Yong Zhou, Zhaohua Li, Yinlu Ding, Jianxin Zhang, Qifeng Yang, Yuezhen Wu. Overexpression of S100A4 protein may be associated with the development and progression of pancreatic cancer. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 1): S159 doi: 10.4103/0973-1482.172582
|
| 35 |
Wilson Petrushnko, Justin S. Gundara, Philip R. De Reuver, Greg O'Grady, Jaswinder S. Samra, Anubhav Mittal. Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma. HPB 2016; 18(8): 652 doi: 10.1016/j.hpb.2016.05.004
|
| 36 |
Valeska Hofmeister-Mueller, Claudia S. Vetter-Kauczok, Ramona Ullrich, Katharina Meder, Eugene Lukanidin, Eva-Bettina Broecker, Per thor Straten, Mads Hald Andersen, David Schrama, Juergen C. Becker. Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients. Cancer Immunology, Immunotherapy 2009; 58(8): 1265 doi: 10.1007/s00262-008-0640-0
|
| 37 |
Naoki Ikenaga, Kenoki Ohuchida, Kazuhiro Mizumoto, Jun Yu, Hayato Fujita, Kohei Nakata, Junji Ueda, Norihiro Sato, Eishi Nagai, Masao Tanaka. S100A4 mRNA is a Diagnostic and Prognostic Marker in Pancreatic Carcinoma. Journal of Gastrointestinal Surgery 2009; 13(10): 1852 doi: 10.1007/s11605-009-0978-4
|
| 38 |
HYE YOUN SUNG, EUN NAM CHOI, DAHYUN LYU, AE KYUNG PARK, WOONG JU, JUNG-HYUCK AHN. Aberrant hypomethylation-mediated AGR2 overexpression induces an aggressive phenotype in ovarian cancer cells. Oncology Reports 2014; 32(2): 815 doi: 10.3892/or.2014.3243
|
| 39 |
Marjorie Adjuto-Saccone, Philippe Soubeyran, Julie Garcia, Stéphane Audebert, Luc Camoin, Marion Rubis, Julie Roques, Bernard Binétruy, Juan Lucio Iovanna, Roselyne Tournaire. TNF-α induces endothelial–mesenchymal transition promoting stromal development of pancreatic adenocarcinoma. Cell Death & Disease 2021; 12(7) doi: 10.1038/s41419-021-03920-4
|
| 40 |
Stephan B. Dreyer, Mark Pinese, Nigel B. Jamieson, Christopher J. Scarlett, Emily K. Colvin, Marina Pajic, Amber L. Johns, Jeremy L. Humphris, Jianmin Wu, Mark J. Cowley, Angela Chou, Adnan M. Nagrial, Lorraine Chantrill, Venessa T. Chin, Marc D. Jones, Kim Moran-Jones, Christopher Ross Carter, Euan J. Dickson, Jaswinder S. Samra, Neil D. Merrett, Anthony J. Gill, James G. Kench, Fraser Duthie, David K. Miller, Susanna Cooke, Daniela Aust, Thomas Knösel, Petra Rümmele, Robert Grützmann, Christian Pilarsky, Nam Q. Nguyen, Elizabeth A. Musgrove, Peter J. Bailey, Colin J. McKay, Andrew V. Biankin, David K. Chang. Precision Oncology in Surgery. Annals of Surgery 2020; 272(2): 366 doi: 10.1097/SLA.0000000000003143
|
| 41 |
Xue Sun, Siyuan Wang, Catherine C.L. Wong. Mass spectrometry–based proteomics technology in pancreatic cancer research. Journal of Pancreatology 2024; 7(2): 145 doi: 10.1097/JP9.0000000000000152
|